European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours
出版年份 2023 全文链接
标题
European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours
作者
关键词
-
出版物
JOURNAL OF NEUROENDOCRINOLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2023-10-05
DOI
10.1111/jne.13343
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Prediction of R Status in Resections for Pancreatic Cancer Using Simplified Radiological Criteria
- (2022) Louisa Bolm et al. ANNALS OF SURGERY
- Update on the clinical management of multiple endocrine neoplasia type 1
- (2022) Carolina R. C. Pieterman et al. CLINICAL ENDOCRINOLOGY
- Comparative outcomes of pancreatic neuroendocrine neoplasms: A population-based analysis of the SEER database
- (2022) Zhen Yang et al. EJSO
- Efficacy and safety of 177Lu‑DOTATATE in patients with advanced pancreatic neuroendocrine tumours: data from the NETTER-R international, retrospective study
- (2022) Dominique Clement et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors
- (2022) Sara Pusceddu et al. JAMA Network Open
- A Single-Center Prospective Observational Study Investigating the Accuracy of Preoperative Diagnostic Procedures in the Assessment of Lymph Node Metastases in Nonfunctioning Pancreatic Neuroendocrine Tumors
- (2022) Stefano Partelli et al. ANNALS OF SURGERY
- A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: Final analysis of efficacy and evaluation of MGMT (ECOG-ACRIN E2211).
- (2022) Pamela L. Kunz et al. JOURNAL OF CLINICAL ONCOLOGY
- The evolution of PRRT for the treatment of neuroendocrine tumors; What comes next?
- (2022) Philip E. Harris et al. Frontiers in Endocrinology
- Portal vein resection during pancreaticoduodenectomy for pancreatic neuroendocrine tumors. An international multicenter comparative study
- (2021) Giuseppe K. Fusai et al. SURGERY
- The Safety and Efficacy of the Repeated PRRT with [90Y]Y/[177Lu]Lu-DOTATATE in Patients with NET
- (2021) Anna Zemczak et al. International Journal of Endocrinology
- Consensus on molecular imaging and theranostics in neuroendocrine neoplasms
- (2021) Valentina Ambrosini et al. EUROPEAN JOURNAL OF CANCER
- Surgical feasibility, Determinants and overall Efficacy assessment of Neoadjuvant PRRT with 177Lu-DOTATATE for Locally Advanced Unresectable Gastroenteropancreatic Neuroendocrine Tumors
- (2021) Rahul V Parghane et al. JOURNAL OF NUCLEAR MEDICINE
- Semi-automatic tumor delineation for evaluation of 64Cu-DOTATATE PET/CT in patients with neuroendocrine neoplasms: prognostication based on lowest lesion uptake and total tumor volume
- (2021) Esben Andreas Carlsen et al. JOURNAL OF NUCLEAR MEDICINE
- High vimentin expression with E-cadherin expression loss predicts a poor prognosis after resection of grade 1 and 2 pancreatic neuroendocrine tumors
- (2021) Bo Zhou et al. BMC CANCER
- A multigenomic liquid biopsy biomarker for neuroendocrine tumor disease outperforms CgA and has surgical and clinical utility
- (2021) I.M. Modlin et al. ANNALS OF ONCOLOGY
- Reconsideration of Clinicopathologic Prognostic Factors in Pancreatic Neuroendocrine Tumors for Better Determination of Adverse Prognosis
- (2021) Anil Aysal et al. ENDOCRINE PATHOLOGY
- International Validation of a Nomogram to Predict Recurrence after Resection of Grade 1 and 2 Non-Functioning Pancreatic Neuroendocrine Tumors
- (2021) Charlotte M. Heidsma et al. NEUROENDOCRINOLOGY
- Temozolomide in Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Retrospective Review
- (2021) David L. Chan et al. ONCOLOGIST
- The Impact of 68Gallium DOTA PET/CT in Managing Patients With Sporadic and Familial Pancreatic Neuroendocrine Tumours
- (2021) Daniel J. Cuthbertson et al. Frontiers in Endocrinology
- Efficacy and safety of high-dose lanreotide autogel in patients with progressive pancreatic or midgut neuroendocrine tumours: CLARINET FORTE phase 2 study results
- (2021) Marianne Pavel et al. EUROPEAN JOURNAL OF CANCER
- Belzutifan for Renal Cell Carcinoma in von Hippel–Lindau Disease
- (2021) Eric Jonasch et al. NEW ENGLAND JOURNAL OF MEDICINE
- A meta-analysis of the accuracy of a neuroendocrine tumor mRNA genomic biomarker (NETest) in blood
- (2020) K. Öberg et al. ANNALS OF ONCOLOGY
- Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study
- (2020) Jonathan Strosberg et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Outcomes after distal pancreatectomy for neuroendocrine neoplasms: a retrospective comparison between minimally invasive and open approach using propensity score weighting
- (2020) Stefano Partelli et al. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
- Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2020) M. Pavel et al. ANNALS OF ONCOLOGY
- Clues For Genetic Anticipation In Multiple Endocrine Neoplasia Type 1
- (2020) Medard F M van den Broek et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Prospective Evaluation of the NETest as a Liquid Biopsy for Gastroenteropancreatic and Bronchopulmonary Neuroendocrine Tumours: An ENETS Centre of Excellence Experience
- (2020) Anna Malczewska et al. NEUROENDOCRINOLOGY
- Peptide Receptor Radionuclide Therapy for the Treatment of Pancreatic Neuroendocrine Tumors: Recent Insights
- (2020) Jason S Starr et al. OncoTargets and Therapy
- Prognostic factors for the outcome of nonfunctioning pancreatic neuroendocrine tumors in MEN1: a systematic review of literature
- (2020) S M Sadowski et al. ENDOCRINE-RELATED CANCER
- 18F-FDG-PET is superior to WHO grading as prognostic tool in neuroendocrine neoplasms and useful in guiding peptide receptor radionuclide therapy: a prospective 10-year follow-up study of 166 patients
- (2020) Tina Binderup et al. JOURNAL OF NUCLEAR MEDICINE
- Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When Ki‐67 Is ≥10%?
- (2020) Elettra Merola et al. ONCOLOGIST
- Peptide receptor radiotherapy re-treatment in patients with progressive neuroendocrine tumors: A systematic review and meta-analysis
- (2020) Jonathan Strosberg et al. CANCER TREATMENT REVIEWS
- Temozolomide alone or combined to capecitabine for the treatment of advanced pancreatic NET
- (2019) Louis de Mestier et al. NEUROENDOCRINOLOGY
- A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy After Resection of Pancreatic Neuroendocrine Tumors
- (2019) Mohammad Y. Zaidi et al. ANNALS OF SURGERY
- Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors
- (2019) Alessandra Pulvirenti et al. ANNALS OF SURGERY
- The 2019 WHO classification of tumours of the digestive system
- (2019) Iris D. Nagtegaal et al. HISTOPATHOLOGY
- Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU Study
- (2019) Alberto Carmona-Bayonas et al. JOURNAL OF CLINICAL ONCOLOGY
- Peritoneal carcinomatosis in gastro-entero-pancreatic neuroendocrine neoplasms: clinical impact and effectiveness of the available therapeutic options
- (2019) ELETTRA MEROLA et al. NEUROENDOCRINOLOGY
- Prospective study of chromogranin A as a predictor of progression in patients with pancreatic, small intestinal and unknown primary neuroendocrine tumors.
- (2019) Gitte Dam et al. NEUROENDOCRINOLOGY
- The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors
- (2019) Anna Malczewska et al. Advances in Medical Sciences
- Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you?
- (2019) Andrew M Bellizzi HUMAN PATHOLOGY
- Tumor burden score predicts tumor recurrence of non-functional pancreatic neuroendocrine tumors after curative resection
- (2019) Ding-Hui Dong et al. HPB
- Contrast harmonic EUS for the prediction of pancreatic neuroendocrine tumor aggressiveness (with videos)
- (2018) Maxime Palazzo et al. GASTROINTESTINAL ENDOSCOPY
- Clinical and Biomarker Evaluations of Sunitinib in Patients with Grade 3 Digestive Neuroendocrine Neoplasms
- (2018) Anna Pellat et al. NEUROENDOCRINOLOGY
- Peptide receptor radionuclide therapy as neoadjuvant therapy for resectable or potentially resectable pancreatic neuroendocrine neoplasms
- (2018) Stefano Partelli et al. SURGERY
- 68Ga PET Imaging in Patients With Neuroendocrine Tumors
- (2018) Simron Singh et al. CLINICAL NUCLEAR MEDICINE
- Peptide Receptor Radionuclide Therapy in Grade 3 Neuroendocrine Neoplasms: Safety and Survival Analysis in 69 Patients
- (2018) Jingjing Zhang et al. JOURNAL OF NUCLEAR MEDICINE
- Patterns of recurrence after resection for pancreatic neuroendocrine tumors: who, when, and where?
- (2018) Giovanni Marchegiani et al. NEUROENDOCRINOLOGY
- Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicenter cohort study
- (2018) Esben Andreas Carlsen et al. ENDOCRINE-RELATED CANCER
- Safety of multiple repeated cycles of 177Lu-octreotate in patients with recurrent neuroendocrine tumour
- (2017) Anna Yordanova et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysis
- (2017) Sue Ping Thang et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Neuroendocrine liver metastases: Vascular patterns on triple-phase MDCT are indicative of primary tumour location
- (2017) Maxime Ronot et al. EUROPEAN JOURNAL OF RADIOLOGY
- National Rise of Primary Pancreatic Carcinoid Tumors: Comparison to Functional and Nonfunctional Pancreatic Neuroendocrine Tumors
- (2017) Gyulnara G. Kasumova et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Whole-genome landscape of pancreatic neuroendocrine tumours
- (2017) Aldo Scarpa et al. NATURE
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging
- (2017) Anders Sundin et al. NEUROENDOCRINOLOGY
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pathology - Diagnosis and Prognostic Stratification
- (2017) Aurel Perren et al. NEUROENDOCRINOLOGY
- Everolimus in Pancreatic Neuroendocrine Carcinomas G3
- (2017) Francesco Panzuto et al. PANCREAS
- Gastroenteropancreatic neuroendocrine tumors: impact of consistent contrast agent selection on radiologists’ confidence in hepatic lesion assessment on restaging MRIs
- (2017) Patricia Balthazar et al. Abdominal Radiology
- Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
- (2017) Arvind Dasari et al. JAMA Oncology
- Utility of chromogranin A, pancreatic polypeptide, glucagon and gastrin in the diagnosis and follow-up of pancreatic neuroendocrine tumours in multiple endocrine neoplasia type 1 patients
- (2016) Wei Qiu et al. CLINICAL ENDOCRINOLOGY
- Evaluation of Magnetic Resonance (MR) Biomarkers for Assessment of Response With Response Evaluation Criteria in Solid Tumors
- (2016) Gustavo Felipe Luersen et al. JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY
- Head-to-Head Comparison of 64 Cu-DOTATATE and 68 Ga-DOTATOC PET/CT: A Prospective Study of 59 Patients with Neuroendocrine Tumors
- (2016) Camilla B. Johnbeck et al. JOURNAL OF NUCLEAR MEDICINE
- Not All Patients with a Pancreatic Neuroendocrine Tumour Will Benefit from All Approved or Recommended Therapeutic Options: A Real-Life Retrospective Study
- (2016) Amandine Berdelou et al. NEUROENDOCRINOLOGY
- ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors
- (2016) M. Falconi et al. NEUROENDOCRINOLOGY
- Imaging Tests for the Diagnosis and Staging of Pancreatic Adenocarcinoma
- (2016) Jonathan R. Treadwell et al. PANCREAS
- Efficacy of endoscopic ultrasonography and endoscopic ultrasonography-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors
- (2015) Nao Fujimori et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
- (2014) Martyn E. Caplin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of radiological prognostic factors of hepatic metastases in patients with non-functional pancreatic neuroendocrine tumors
- (2013) Timm Denecke et al. EUROPEAN JOURNAL OF RADIOLOGY
- Loss of DAXX and ATRX Are Associated With Chromosome Instability and Reduced Survival of Patients With Pancreatic Neuroendocrine Tumors
- (2013) Ilaria Marinoni et al. GASTROENTEROLOGY
- ISL1 expression is not restricted to pancreatic well-differentiated neuroendocrine neoplasms, but is also commonly found in well and poorly differentiated neuroendocrine neoplasms of extrapancreatic origin
- (2013) Abbas Agaimy et al. MODERN PATHOLOGY
- High Sensitivity of Diffusion-weighted MR Imaging for the Detection of Liver Metastases from Neuroendocrine Tumors: Comparison with T2-weighted and Dynamic Gadolinium-enhanced MR Imaging
- (2013) Gaspard d’Assignies et al. RADIOLOGY
- Molecular pathology and genetics of pancreatic endocrine tumours
- (2012) Gabriele Capurso et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Metastatic and Locally Advanced Pancreatic Endocrine Carcinomas: Analysis of Factors Associated With Disease Progression
- (2011) Francesco Panzuto et al. JOURNAL OF CLINICAL ONCOLOGY
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
- (2011) Eric Raymond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Everolimus for Advanced Pancreatic Neuroendocrine Tumors
- (2011) James C. Yao et al. NEW ENGLAND JOURNAL OF MEDICINE
- DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
- (2011) Y. Jiao et al. SCIENCE
- First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas
- (2010) Jonathan R. Strosberg et al. CANCER
- Ki-67 index, tumor differentiation, and extent of liver involvement are independent prognostic factors in patients with liver metastases of digestive endocrine carcinomas
- (2010) O. Hentic et al. ENDOCRINE-RELATED CANCER
- Prognostic Score Predicting Survival After Resection of Pancreatic Neuroendocrine Tumors
- (2009) Karl Y. Bilimoria et al. ANNALS OF SURGERY
- Asymptomatic Children with Multiple Endocrine Neoplasia Type 1 Mutations May Harbor Nonfunctioning Pancreatic Neuroendocrine Tumors
- (2009) Paul J. Newey et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search